PDZRN4 acts as a suppressor of cell proliferation in human liver cancer cell lines

Taotao Hu1,2, Hong Yang1,3, Ze-Guang Han1,4,2

  • 1Key Laboratory of Systems Biomedicine (Ministry of Education) of Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Insights

PDZ domain containing ring finger 4 (PDZRN4) is down-regulated in hepatocellular carcinoma (HCC). Restoring PDZRN4 expression inhibits HCC cell proliferation, suggesting it acts as a tumor suppressor gene.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatology

Background:

  • Ligand of Numb Protein-X 1 (LNX1) is implicated as a suppressor gene in gliomas.
  • The role of PDZRN4 (also known as LNX4), another LNX family member, in hepatocellular carcinoma (HCC) progression was previously unstudied.
  • LNX gene family members play diverse roles in cellular processes.

Purpose of the Study:

  • To investigate the expression levels of PDZRN4 in HCC.
  • To determine the functional role of PDZRN4 in HCC cell proliferation and colony formation.
  • To evaluate PDZRN4 as a potential tumor suppressor in HCC.

Main Methods:

  • Semi-quantitative polymerase chain reaction (PCR) to assess PDZRN4 expression in HCC tissues and cell lines.
  • Cell-based functional assays to evaluate the impact of PDZRN4 ectopic expression on HCC cell proliferation, colony formation, and anchorage-independent growth.

Main Results:

  • PDZRN4 was found to be down-regulated in 66.7% of HCC samples compared to adjacent non-cancerous tissues.
  • PDZRN4 expression was silenced in all 12 tested HCC cell lines.
  • Ectopic expression of PDZRN4 significantly inhibited HCC cell proliferation, plate colony formation, and anchorage-independent colony formation.

Conclusions:

  • PDZRN4 exhibits down-regulation and silencing in hepatocellular carcinoma.
  • PDZRN4 demonstrates anti-proliferative effects on HCC cells.
  • PDZRN4 is identified as a potential tumor suppressor gene in HCC, significant for future research.